Common · Knowledge
Darolutamide
Chemical compound
Darolutamide, sold under the brand name Nubeqa, is an antiandrogen medication which is used in the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) in men. It is specifically approved to treat nmCRPC in conjunction with surgical or medical castration.
From Wikipedia
Darolutamide, sold under the brand name Nubeqa, is an antiandrogen medication which is used in the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) in men. It is specifically approved to treat nmCRPC in conjunction with surgical or medical castration. The medication is taken by mouth twice per day with food. Side effects of darolutamide added to castration may include fatigue, asthenia, pain in the arms and legs, and rash. Darolutamide is a nonsteroidal antiandrogen (NSAA), and acts as a selective antagonist of the androgen receptor (AR). It has been referred to as a second- or third-generation NSAA. Darolutamide was patented in 2011 and was approved for medical use in USA in July 2019, in the European Union in March 2020 in Australia in July 2020. and in Canada in 2020,
Text: Wikipédia, CC BY-SA 4.0. ·
